InsiderClue
Insiders · Profile

Abrahmsen Lars B.

SVP, Chief Scientific Officer at Aprea Therapeutics. Filing since 20 Sep 2021. CIK 0001789039

Company
Date
Role
Action
Shares
Amount
Of holding
APRE Aprea Therapeutics, Inc.
1 Oct 2021
SVP, Chief Scientific Officer
Sold, plan not stated
50,000
$244.50K
72.5%
APRE Aprea Therapeutics, Inc.
20 Sep 2021
SVP, Chief Scientific Officer
Sold, plan not stated
25,000
$124.25K
56.8%
2 decisions on file.